In their studies Jäckel et al. identified an oligodendroglial subcluster termed immune oligodendroglia (ImOLG) expressing among other markers CD74 and HLA-DRA which were enriched in MS brains [23]. This evidence concerns the gene HLA-DRA and myeloid sarcoma.